Dear Investor,

My track record in crypto speaks for itself:

• KDA: 17,556%

• PRE: 3,900%

• OCEAN: 2,650%

• ALBT: 1,933%

Every single one of these was recommended to our community before the big move happened.

Today, I'm making my next big call.

It's a coin under $1.00 that most investors have never heard of. But the world's largest bank is already building on it. It has a deflationary burn mechanism tied directly to institutional usage. 

And its biggest supply cut in history just happened weeks ago.

With Bitcoin down 45% and the market stuck in extreme fear for nearly three weeks straight, this is the exact environment where my biggest winners have been found.

Low prices. High fundamentals. Maximum fear. Institutional accumulation happening in the background.

I've seen this movie before. And I believe this coin could deliver returns that rival—or exceed—any pick I've ever made.

The full report is usually $97. On this page today, it's $3:

Get my #1 coin now… while it's still under $1.

To your massive success,

Bryce Paul
Crypto 101

5 Stocks the Market Rewarded After Strong Earnings Results

Reported by Ryan Hasson. Article Published: 8/10/2026.

This earnings season has delivered a hard lesson: Beating estimates is no longer enough. Several richly valued names posted strong quarters only to sell off sharply as the market picked apart their guidance, bookings or spending plans. That makes the stocks that beat expectations and either held their gains or extended them worth watching closely. When a stock absorbs good news and keeps climbing while the broader market wobbles, it usually means institutional investors are genuinely accumulating shares rather than selling into strength.

Five names stand out right now, spanning several sectors, and each earned its resilience with results that answered the market's biggest questions. For investors looking for durable leadership in a choppy market, these five names are worth a closer look.

Amazon: The $200 Billion Quarter That Reset the AI Debate

Amazon (NASDAQ: AMZN) is up nearly 19% year to date, ranking among the top-rated names in the entire consumer discretionary sector according to MarketBeat's MarketRank. Its Q2 report explains why that strength has persisted. Revenue crossed $200 billion in a single quarter for the first time in company history, rising 20% year over year to $200.6 billion. The star was AWS, which accelerated to 37% growth, its fastest pace in 18 quarters, easily surpassing the 31% analysts expected. AWS operating income of $16.6 billion also crushed the roughly $13.6 billion consensus, while the cloud backlog reached a staggering $496 billion.

Two pieces of management commentary did the heavy lifting. CEO Andy Jassy revealed that Amazon's AI and chips businesses have each surpassed $25 billion in annualized revenue, and he told investors that AWS could eventually become a trillion-dollar annual revenue business. That reframed the roughly $220 billion capital expenditure (CapEx) plan as a response to demand rather than a leap of faith. The stock surged more than 10% after the report, then hit a record high and crossed the $3 trillion valuation mark before dipping back to $2.96 trillion. The consensus among 59 analysts is Moderate Buy, with a price target of $322.56 implying nearly 18% upside potential. From a technical perspective, the stock has digested its earnings surge well, and a break above $280 could mark the start of a fresh leg higher.

Microsoft: From Worst in the Mag 7 to a Vertical Recovery

Microsoft (NASDAQ: MSFT) tells the season's most dramatic before-and-after story. The stock entered its July 29 report down nearly 19% for the year, making it the clear laggard among mega-cap technology names. It had been weighed down by fears that AI spending was outpacing monetization. Then one report changed everything. Fourth-quarter fiscal 2026 revenue of $90.01 billion grew almost 18% and beat the $87.6 billion consensus, while adjusted earnings per share (EPS) of $4.74 topped the $4.24 estimate. However, investors should note that investment gains tied to its Anthropic and OpenAI stakes contributed meaningfully to the beat.

The core of the story was Azure, which accelerated to 43% growth and crossed $100 billion in annual revenue for the first time in company history. Microsoft 365 Copilot surpassed 30 million paid seats, evidence that enterprise AI adoption is translating into real subscription revenue. Critically, CFO Amy Hood told investors that the calendar 2026 CapEx forecast remains unchanged, removing the single biggest overhang on the stock.

Shares surged after the release, added hundreds of billions of dollars in market value within days and have rallied roughly 28% over the past month. The consensus among 47 analysts is Moderate Buy, with a $558.87 target implying nearly 12% upside. The stock is slightly overbought, however, so investors looking to enter MSFT might be better off waiting for a measured pullback and confirmation of a higher low within its newfound uptrend.

JPMorgan Chase: The Bank Leading the Market's Quiet Rotation

JPMorgan Chase (NYSE: JPM) is up more than 10% year to date, comfortably ahead of the financial sector benchmark. It trades within about 2% of its 52-week high, with a market cap approaching the unprecedented $1 trillion mark for a U.S. bank. The Q2 report on July 14 was the catalyst for the run. Revenue of nearly $58 billion and EPS of $6.14 easily surpassed expectations, driven by strong loan growth and what is shaping up to be a record year for Wall Street's trading desks.

The capital-return story adds a second leg. Having cleared the Fed's stress test, JPMorgan is widely expected to deliver a double-digit dividend increase in September, layering income growth on top of price strength. The analyst community has leaned in, with Deutsche Bank upgrading the stock from Hold to Buy and assigning a $375 target in late July. With a strong dividend rating, outlier sector performance and relative strength, JPMorgan remains the sector's standard-bearer as financials show genuine leadership while pockets of technology correct.

Johnson & Johnson: A Raised Outlook and a Historic Milestone in Sight

Johnson & Johnson (NYSE: JNJ) is up more than 25% year to date, one of the strongest showings among mega-cap healthcare names and a remarkable run for a stock with one of the market's lowest volatility profiles. The Q2 report on July 15 delivered a clean beat, with adjusted EPS of $2.90 topping the $2.85 consensus and revenue of $25.31 billion rising 6.6% to exceed estimates. Management raised full-year guidance on both lines and confirmed that the company is on track to surpass $100 billion in annual revenue for the first time in its 140-year history.

The standout detail was the immunology drug Tremfya, which generated $2 billion in quarterly sales, up 72.5% and well above the roughly $1.74 billion analysts had modeled. That eased fears about erosion from Stelara biosimilars. Analysts hold a consensus Moderate Buy rating with an average target price near $268.22, implying nearly 4% upside potential. The dividend has now been raised for more than six consecutive decades. It’s clear from the chart that JNJ has strong momentum. The stock is holding well above all its key moving averages and trading roughly 5.5% below its 52-week high. Key levels to watch are the $250 support area and the $270 resistance level, which also represents a potential breakout point.

Coca-Cola: Volume Strength Not Seen in 17 Years

Coca-Cola (NYSE: KO) is up nearly 25% year to date, several times the gain of the consumer staples benchmark. Its July 28 report showed why the momentum is fundamental rather than merely the result of a defensive rotation. Comparable EPS of 97 cents grew 11% and beat the 93-cent consensus, while revenue of $13.37 billion rose 6.2% and also topped estimates, extending a beat streak that now spans five consecutive quarters. The stock jumped 5% on the day, reaching a fresh 52-week high.

The detail that caught Wall Street's attention was volume. Trademark Coca-Cola volume grew 5% across all geographic segments, the strongest growth in 17 years outside the COVID recovery. Coca-Cola Zero Sugar led the gains, surging 16%, while the FIFA World Cup activation provided a global tailwind. Notably, management raised full-year guidance to 9%-10% comparable EPS growth. For a 64-year Dividend King yielding nearly 2.5%, that is growth-stock behavior from a defensive stalwart. Analysts are bullish on the name, with a consensus Moderate Buy rating and a price target implying nearly 10% upside despite its impressive year-to-date gains. From a technical perspective, the stock is positioned for further upside, with a key breakout level near $88 suggesting that its uptrend remains intact.

The Rewarded Few

The common thread across these five is not sector or style. It is that each report answered the exact question the market was asking. Amazon and Microsoft have shown that AI spending is translating into accelerating cloud revenue growth. JPMorgan demonstrated that the financial system can continue compounding through the rate cycle. Johnson & Johnson and Coca-Cola showed that pricing power and strong pipelines still drive growth in defensive franchises. In a season when beats alone have been sold, the market is paying up for answers—and these five delivered them. For investors, the watchlist writes itself. The entries, as always, come down to the technicals.